Fig. 4

Patient Global Impression of Change (PGIC) at weeks 9–12 in the overall patient population (all patients; n = 82, blue bars), in patients with prior failure to monoclonal antibodies targeting CGRP pathway (anti-CGRP mAbs; n = 34, gray bars)